Related Experiment Video

Updated: Jan 9, 2026

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

9.6K

Causal proteomic insights into drug target discovery for tension-type headache

Ran Gao1,2, Renxi Wang3,4, Zhonghua Xiong5

  • 1Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, No. 10 Xitoutiao, You An Men, Beijing, 100093, China.

The Journal of Headache and Pain
|December 2, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Drug targetsMendelian randomizationMetabolismProteomicsTension-type headache

More Related Videos

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
05:49

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders

Published on: November 1, 2024

1.2K
Investigating Migraine-Like Behavior Using Light Aversion in Mice
05:23

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

4.3K

Related Experiment Videos

Last Updated: Jan 9, 2026

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

9.6K
Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
05:49

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders

Published on: November 1, 2024

1.2K
Investigating Migraine-Like Behavior Using Light Aversion in Mice
05:23

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

4.3K

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

16.3K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.3K

Articles linked to this work by shared authors, journal, and citation graph.

PRAME promotes invasion and metastasis of salivary adenoid cystic carcinoma by regulating RARα stability via the cullin2 ubiquitin-proteasome system.

Clinical and translational medicine·2026

Chiral and racemic Dy(III) macrocyclic single-molecule magnets with magnetically enhanced photothermal conversion.

Dalton transactions (Cambridge, England : 2003)·2026

Model-guided deep unfolding network for broadband reconstructive spectrometers with non-orthogonal aliasing.

Optics express·2026

Genome-wide meta-analysis with 1,590,596 individuals identifies 12 novel risk loci for systemic lupus erythematosus.

Mammalian genome : official journal of the International Mammalian Genome Society·2026

Effect of BPM music on post-exercise heart rate variability in male collegiate sprinters.

Frontiers in sports and active living·2026

Case report: Vogt-Koyanagi-Harada-like uveitis induced by anti-PD-1 therapy (Sintilimab) in a gastric cancer patient: a case study.

Frontiers in pharmacology·2026

Integrative genetic analysis identifies shared regulation of DNA methylation and gene expression in migraine risk.

The journal of headache and pain·2026

Headache-attributed burden among children and adolescents in Nepal: a national schools-based cross-sectional study.

The journal of headache and pain·2026

Headache-attributed burden among children and adolescents in Georgia: estimates from a national cross-sectional schools-based study.

The journal of headache and pain·2026

Pain in Parkinson's disease: bridging pathophysiology, clinical features, and personalized management.

The journal of headache and pain·2026

Migraine immune cell gene targets and their relationship to psychiatric disorders.

The journal of headache and pain·2026

Botulinum toxin type A attenuates trigeminal neuralgia-like pain by suppressing CGRP release and modulating NaV1.7-associated signaling.

The journal of headache and pain·2026

Can Telehealth Improve Access to Amyloid-Targeting Therapies for Veterans Living With Alzheimer Disease?

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026

Correction to: Sustained release microneedle patch for pronounced systemic delivery of doxazosin mesylate.

BioImpacts : BI·2026

A Nomogram Integrating Clinical and Cardiac Imaging for Predicting Short-Term Left Ventricular Ejection Fraction Decline in Patients with Duchenne Muscular Dystrophy.

International journal of general medicine·2026

Metformin modulates the phenotypes of tumor-associated macrophages in glioblastoma in a context-dependent manner by promoting the homeostasis of macrophages.

Frontiers in oncology·2026

OAF Blocks SIAH1-Mediated Degradation of SCPX, a Therapeutic Strategy for MASLD.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Real World Data and Its Impact on the Management of Plasma Cell Dyscrasias.

Current hematologic malignancy reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us